Getinge AB (publ) (OTCMKTS:GNGBY – Get Rating) has been assigned an average recommendation of “Hold” from the seven research firms that are presently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $297.00.
Several brokerages recently weighed in on GNGBY. Kepler Capital Markets downgraded Getinge AB (publ) from a “buy” rating to a “hold” rating and decreased their price target for the stock from SEK 435 to SEK 280 in a report on Monday, June 13th. Cheuvreux lowered Getinge AB (publ) from a “buy” rating to a “hold” rating and decreased their price target for the stock from SEK 435 to SEK 280 in a research note on Monday, June 13th. JPMorgan Chase & Co. dropped their target price on Getinge AB (publ) from SEK 344 to SEK 331 and set a “neutral” rating on the stock in a report on Wednesday, July 20th. Finally, Nordea Equity Research downgraded Getinge AB (publ) from a “buy” rating to a “hold” rating in a report on Wednesday, June 15th.
Getinge AB (publ) Price Performance
OTCMKTS:GNGBY opened at $21.51 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.11 and a quick ratio of 1.39. The firm has a market cap of $5.47 billion, a price-to-earnings ratio of 20.10 and a beta of 1.18. The company has a 50 day moving average price of $24.72 and a 200-day moving average price of $32.34. Getinge AB has a 1-year low of $19.93 and a 1-year high of $48.89.
Getinge AB (publ) (OTCMKTS:GNGBY – Get Rating) last issued its quarterly earnings data on Tuesday, April 26th. The company reported $0.23 earnings per share (EPS) for the quarter. Getinge AB (publ) had a net margin of 9.90% and a return on equity of 12.68%. The firm had revenue of $661.90 million for the quarter. Equities research analysts forecast that Getinge AB will post 1.11 EPS for the current year.
About Getinge AB (publ)
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products.
Featured Articles
- Get a free copy of the StockNews.com research report on Getinge AB (publ) (GNGBY)
- 3 Large Caps With Bullish Chart Patterns
- Medtronic Stock Keeps Ticking Forward
- Occidental Petroleum Leads Exxon Mobil, Chevron Ahead Of Next Week’s Earnings
- The Bull and Bear Case for Investing in AMD
- Simpson Manufacturing Quietly Builds Foundations For Growth
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Getinge AB (publ) Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Getinge AB (publ) and related companies with MarketBeat.com’s FREE daily email newsletter.